IE37942L - Carbazoles - Google Patents

Carbazoles

Info

Publication number
IE37942L
IE37942L IE731252A IE125273A IE37942L IE 37942 L IE37942 L IE 37942L IE 731252 A IE731252 A IE 731252A IE 125273 A IE125273 A IE 125273A IE 37942 L IE37942 L IE 37942L
Authority
IE
Ireland
Prior art keywords
amino
group
lower alkyl
formula
lower alkoxy
Prior art date
Application number
IE731252A
Other versions
IE37942B1 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IE37942L publication Critical patent/IE37942L/en
Publication of IE37942B1 publication Critical patent/IE37942B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/86Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

1385620 Carbazoles F HOFFMANN-LA ROCHE & CO AG 23 July 1973 [24 July 1972] 34968/73 Heading C2C The invention comprises compounds of the formula wherein R represents a hydrogen or halogen atom or a hydroxy, cyano, lower alkyl, hydroxy-(lower alkyl), lower alkoxy, acyl, benzyloxy, lower alkylthio, trifluoromethyl, carboxy, carbo-(lower alkoxy), nitro, amino, mono- (lower alkyl)amino, di(lower alkyl)amino, sulphamoyl, di(lower alkyl)sulphamoyl or difluoromethylsulphonyl group and R 1 represents a halogen atom or a hydroxy, cyano, lower alkyl, hydroxy-(lower alkyl), lower alkoxy, acyl, acylamido, benzyloxy, lower alkylthio, trifluoromethyl, carboxy, carbo-(lower alkoxy), nitro, amino, mono(lower alkyl)amino, di- (lower alkyl)amino, sulphamoyl, di(lower alkyl) - sulphamoyl or difluoromethylsulphonyl group or R and R 1 together represent a lower alkylenedioxy group, R 2 represents the grouping in which A represents a cyano, hydroxy, lower alkoxy, amino(lower alkoxy), mono(lower alkyl)- amino-(lower alkoxy), di(lower alkyl)amino- (lower alkoxy) group or the grouping wherein B represents a hydroxy, carboxy, lower alkoxy, amino, hydroxyamino, mono(lower alkyl)amino, di(lower alkyl)amino, amino-(lower alkoxy), mono(lower alkyl)amino-(lower alkoxy), di(lower alkyl)amino - (lower alkoxy) group, Y and X each represent a hydrogen atom or a lower alkyl group and n stands for 1 to 7, and R 3 represents a hydrogen atom or a lower alkyl, acyl, halo-substituted acyl, carboxy- (lower alkyl), (lower alkoxycarbonyl)-(lower alkyl), aralkyl or haloaralkyl group, or R 1 represents a hydrogen atom when R, X and R 3 each represent a hydrogen atom, Y represents a lower alkyl group and B represents a hydroxy or lower alkoxy group, and, when R or R 1 represents a carboxy and/or when B represents a hydroxy or carboxy group, salts thereof with bases and, when R or R 1 represents an amino or mono (lower alkyl)amino or di(lower alkyl)amino group and/or when B or A represents an amino- (lower alkoxy) or mono(lower alkyl)amino- (lower alkoxy) or di(lower alkyl)amino-(lower alkoxy) group, addition salts thereof with acids. The term lower alkyl means an alkyl group of 1-7 carbon atoms, acyl means alkanoyl derived from a carboxylic acid containing 1-7 carbon atoms and aryl means phenyl optionally substituted by halogen, trifluoromethyl, lower alkyl, lower alkoxy, nitro, amino, lower alkylamino and di(lower alkyl)amino. The compounds may be prepared by reacting a compound of the formula with an aromatizing agent, for the manufacture of an ester of Formula I in which R or R 1 represents a carbo-(lower alkoxy) group or B represents a lower alkoxy group esterifying an acid of Formula I in which R or R 1 represents a carboxy group or B represents a hydroxy group, for the manufacture of an acid of Formula I in which R or R 1 represents a carboxy group, R 3 represents a carboxy-(lower alkyl) group or B represents a hydroxy group hydrolysing an ester of Formula I in which R or R 1 represents a carbo-(lower alkoxy) group, R 3 represents a (lower alkoxycarbonyl)-(lower alkyl) group or B represents a lower alkoxy group, for the manufacture of a compound of Formula I in which R 1 represents an amino group reacting a compound of Formula I in which R 1 represents an acylamido group with an inorganic acid, if desired replacing a hydrogen atom denoted by R 3 in a compound of Formula I by an acyl or (lower alkoxycarbonyl)-(lower alkyl) group, for the manufacture of a compound of Formula I in which R or R 1 represents a di(lower alkyl)amino group alkylating a compound of Formula I in which R or R 1 represents an amino group, for the manufacture of a compound of Formula I in which R, R 1 or A represents a hydroxy group hydrolysing an ether of Formula I in which R, R 1 or A represents a lower alkoxy group, if desired converting a compound of Formula I in which A represents a hydroxy group into a compound of Formula I in which A represents a lower alkoxy, amino-(lower alkoxy), mono(lower alkyl)amino- (lower alkoxy) or di(lower alkyl)amino-(lower alkoxy) group, for the manufacture of an alcohol of Formula I in which A represents a hydroxy group reducing an ester of Formula I in which B represents a lower alkoxy group, if desired converting a hydroxy group denoted by B in an acid of Formula I or in a salt of such an acid with a base into an amino-(lower alkoxy), mono(lower alkyl)amino-(lower alkoxy) or di- (lower alkyl)amino-(lower alkoxy) group, for the manufacture of an optically active isomer of a compound of Formula I resolving a racemate of Formula I into its optically active isomers and isolating the desired isomer and for the manufacture of a salt of a compound of Formula I in which R or R 1 represents a carboxy group and/or B represents a hydroxy or carboxy group or in which R or R 1 represents an amino, mono(lower alkyl)amino or di(lower alkyl)amino group and/or B or A represents an amino-(lower alkoxy), mono(lower alkyl)amino- (lower alkoxy) or di(lower alkyl)amino-(lower alkoxy) group reacting such a compound of Formula I with a base or an acid. The compounds may be used as anti-inflammatory, analgesic and anti-rheumatic agents. [GB1385620A]
IE1252/73A 1972-07-24 1973-07-23 Carbazoles IE37942B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27414272A 1972-07-24 1972-07-24

Publications (2)

Publication Number Publication Date
IE37942L true IE37942L (en) 1974-01-24
IE37942B1 IE37942B1 (en) 1977-11-23

Family

ID=23046965

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1252/73A IE37942B1 (en) 1972-07-24 1973-07-23 Carbazoles

Country Status (26)

Country Link
JP (1) JPS5740144B2 (en)
KR (1) KR780000289B1 (en)
AR (1) AR205331A1 (en)
AT (1) AT325607B (en)
AU (1) AU475534B2 (en)
BE (1) BE802596A (en)
CA (1) CA1026348A (en)
CH (1) CH587819A5 (en)
DD (1) DD107681A5 (en)
DE (1) DE2337340C2 (en)
DK (1) DK138537B (en)
FI (1) FI59244C (en)
FR (1) FR2193611B1 (en)
GB (1) GB1385620A (en)
HK (1) HK49878A (en)
HU (1) HU167611B (en)
IE (1) IE37942B1 (en)
IL (1) IL42799A (en)
KE (1) KE2847A (en)
LU (1) LU68071A1 (en)
MY (1) MY7800315A (en)
NL (1) NL169877C (en)
NO (1) NO142865C (en)
SE (2) SE402283B (en)
SU (1) SU509220A3 (en)
ZA (1) ZA734047B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146542A (en) * 1978-06-12 1979-03-27 Hoffmann-La Roche Inc. Dihydrocarbazole acetic acid and esters thereof
US4150031A (en) * 1978-06-26 1979-04-17 Hoffmann-La Roche Inc. Hydroxy methyl carbazole acetic acid and esters
US4158007A (en) * 1978-08-21 1979-06-12 Hoffmann-La Roche Inc. Carbazole methyl malonates
US4501908A (en) * 1981-03-12 1985-02-26 Hoffmann-La Roche Inc. 2,3-Isopropylidene ribonic acid, 1,4-lactones
JPS6040256U (en) * 1983-08-25 1985-03-20 伊東 璋 Container cleaning machine
EP0234708B1 (en) * 1986-01-23 1991-02-27 Merck Frosst Canada Inc. Tetrahydrocarbazole 1-alkanoic acids
DE3786030T2 (en) 1986-03-27 1993-12-02 Merck Frosst Canada Inc Tetrahydrocarbazole esters.
EP0307077A1 (en) * 1987-07-21 1989-03-15 Merck Frosst Canada Inc. Tetrahydrocarbazoles for the improvement of cyclosporin therapy
CA1326030C (en) * 1987-07-21 1994-01-11 John W. Gillard Cyclohept[b]indolealkanoic acids
PT95692A (en) * 1989-10-27 1991-09-13 American Home Prod PROCESS FOR THE PREPARATION OF INDOLE-, INDENO-, PYRANOINDOLE- AND TETRA-HYDROCARBAZOLE-ALCANOIC ACID DERIVATIVES, OR WHICH ARE USEFUL AS PLA2 INHIBITORS AND LIPOXIGENASE
JP2004010601A (en) * 2002-06-11 2004-01-15 Nippon Steel Chem Co Ltd Method for producing indole derivative and intermediate useful for the same
WO2004064771A2 (en) * 2003-01-14 2004-08-05 Merck & Co., Inc. Geminally di-substituted nsaid derivatives as abeta 42 lowering agents
MXPA05011850A (en) * 2003-05-06 2006-05-25 Air Prod & Chem Hydrogen storage reversible hydrogenated of pi-conjugated substrates.
JP2007502251A (en) * 2003-08-15 2007-02-08 ユニヴェルシテ・ラヴァル Monomers, oligomers, and polymers of 2-functionalized and 2,7-difunctionalized carbazoles
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
HUE043827T2 (en) * 2011-11-15 2019-09-30 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd Tricyclic compounds, compositions comprising them and uses thereof
JP5940036B2 (en) * 2013-10-08 2016-06-29 テックフィールズ バイオケム カンパニー リミテッド Positively charged water-soluble prodrugs of aryl- and heteroarylpropionic acids with very fast skin permeability
CN114787130A (en) * 2020-03-25 2022-07-22 捷恩智株式会社 Compound, liquid crystal composition and liquid crystal display element

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD70880A (en) *
US3580926A (en) * 1969-11-10 1971-05-25 Parke Davis & Co Carbazole-4-alkanoic acids and tetrahydrocarbazole-4-alkanoic acids
ZA715217B (en) * 1970-08-20 1972-04-26 Org Nv Anti-inflammatory preparations

Also Published As

Publication number Publication date
NO142865C (en) 1980-11-05
BE802596A (en) 1974-01-21
ATA649773A (en) 1975-01-15
MY7800315A (en) 1978-12-31
FR2193611A1 (en) 1974-02-22
IL42799A (en) 1977-03-31
FR2193611B1 (en) 1976-05-14
DK138537B (en) 1978-09-25
KR780000289B1 (en) 1978-08-10
GB1385620A (en) 1975-02-26
NL7310275A (en) 1974-01-28
IL42799A0 (en) 1973-10-25
AU475534B2 (en) 1976-08-26
JPS5740144B2 (en) 1982-08-25
SU509220A3 (en) 1976-03-30
SE402283B (en) 1978-06-26
IE37942B1 (en) 1977-11-23
NL169877B (en) 1982-04-01
CA1026348A (en) 1978-02-14
NL169877C (en) 1982-09-01
NO142865B (en) 1980-07-28
DD107681A5 (en) 1974-08-12
DE2337340C2 (en) 1985-05-02
SE7605813L (en) 1976-05-21
LU68071A1 (en) 1975-04-11
FI59244B (en) 1981-03-31
DK138537C (en) 1979-03-05
CH587819A5 (en) 1977-05-13
KE2847A (en) 1978-06-30
HU167611B (en) 1975-11-28
AR205331A1 (en) 1976-04-30
FI59244C (en) 1981-07-10
ZA734047B (en) 1974-03-27
HK49878A (en) 1978-09-08
JPS4943973A (en) 1974-04-25
AU5839073A (en) 1975-01-23
AT325607B (en) 1975-10-27
DE2337340A1 (en) 1974-02-14

Similar Documents

Publication Publication Date Title
IE37942L (en) Carbazoles
ES417167A1 (en) Carbazoles
ES2173279T3 (en) METHOD FOR MAKING (S) -3- (AMINOMETILO) -5-METILOHEXANOIC ACID.
FI792259A (en) FOERFARANDE FOER KONTROLL AV FAESTINGAR PAO VARMBLODIGA DJUR GENOM ATT ORALT TILLFOERA DJURET EN FAESTINGSEFFEKTIV MAENGD AV EN 2-ARYL-1,3-CYCLOHEXAN FOERENING SAMT ALKALISKA METALLSALTER OMERIUMS
CO5720995A2 (en) NEW COMPOUND
HK1073303A1 (en) Process for the preparation of dioxane acetic acidesters
GB1180873A (en) Amino-Esters of Substituted 4-Pentynoic-2-Acid, their Salification products and their method of manufacture
ES8106308A1 (en) Beta-lactam antibiotics, their preparation, pharmaceutical compositions containing them and their preparation.
GB1467110A (en) 4-phenyl-5-oxo-heptenoic acids
ES528561A0 (en) A PROCEDURE FOR THE PREPARATION OF NITRO ALIPHATIC COMPOUNDS
ES8304073A1 (en) N-Phenylcarbamate derivatives, process for their preparation, fungicidal compositions and a method for controlling fungi.
GB1285400A (en) Esters of substituted anthranilic acid
ES2000673A6 (en) Biocidal mixture.
KR830002708A (en) Preparation method of alpha-carbamoyl-pyrrolepropionitrile and alpha-carbamoyl-pyrrolepropionitrile-containing preparations and their therapeutic applications
ES8700241A1 (en) 1-Phenyl-imidazole-5-carboxylic acid derivatives, process for their preparation and their use as growth regulators.
PT83667B (en) PROCESS FOR THE PREPARATION OF ACIDS AND {{((3-PYRIDINYL) METHYLENE} AMINO} OXY} -ALCANOIC ACIDS AND ESTERS AND OF PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
RU95107147A (en) Cyclohexanecarboxylic acid derivatives, mixture of isomers thereof or individual isomers and physiologically tolerable salts, and pharmaceutical composition having activity which inhibits enzymic glucose-phosphotase complex of liver
KR880011096A (en) Optically active oxo-isoindolinyl derivatives
ES8706647A1 (en) Cyclopropane derivates.
GB1418784A (en) Phosphorus containing pyrimidine compounds and pesticidal compositions comprising them
GB1438223A (en) Biphenylyl alkanones
GB1443647A (en) Imadazole derivatives and a process for the manufacture thereof
GB1251142A (en)
AU7692796A (en) Process for the preparation of methoxyminophenylglyoxylic acid derivatives
ES2001705A6 (en) Catechol derivatives, a process of preparation thereof, and therapeutical compositions containing the same